Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H40N6O6S |
Molecular Weight | 600.73 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CSCC[C@H](N(C)C(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC2=CC=C(O)C=C2)C(N)=O
InChI
InChIKey=FWDIKROEWJOQIQ-JMBSJVKXSA-N
InChI=1S/C29H40N6O6S/c1-18(33-28(40)22(30)15-20-9-11-21(36)12-10-20)27(39)32-17-25(37)34-23(16-19-7-5-4-6-8-19)29(41)35(2)24(26(31)38)13-14-42-3/h4-12,18,22-24,36H,13-17,30H2,1-3H3,(H2,31,38)(H,32,39)(H,33,40)(H,34,37)/t18-,22+,23+,24+/m1/s1
Molecular Formula | C29H40N6O6S |
Molecular Weight | 600.73 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
PubMed
Title | Date | PubMed |
---|---|---|
Metkephamid, a systemically active analog of methionine enkephalin with potent opioid alpha-receptor activity. | 1981 Feb 6 |
|
Metkephamid (Tyr-D-ala-Gly-Phe-N(Me)Met-NH2), a potent opioid peptide: receptor binding and analgesic properties. | 1982 Sep-Oct |
|
Cardiovascular properties of metkephamid, a delta opioid receptor agonist, in man. | 1985 Feb |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6872419
The efficacy, safety, and time course of analgesia with 70 or 140 mg metkephamid were compared with those of 100 mg meperidine and placebo in 59 hospitalized women with severe postpartum episiotomy pain.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:48:51 GMT 2023
by
admin
on
Fri Dec 15 18:48:51 GMT 2023
|
Record UNII |
MNL20FXH9Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
MNL20FXH9Y
Created by
admin on Fri Dec 15 18:48:51 GMT 2023 , Edited by admin on Fri Dec 15 18:48:51 GMT 2023
|
PRIMARY | |||
|
100000080918
Created by
admin on Fri Dec 15 18:48:51 GMT 2023 , Edited by admin on Fri Dec 15 18:48:51 GMT 2023
|
PRIMARY | |||
|
DTXSID30985694
Created by
admin on Fri Dec 15 18:48:51 GMT 2023 , Edited by admin on Fri Dec 15 18:48:51 GMT 2023
|
PRIMARY | |||
|
CHEMBL2220405
Created by
admin on Fri Dec 15 18:48:51 GMT 2023 , Edited by admin on Fri Dec 15 18:48:51 GMT 2023
|
PRIMARY | |||
|
5464184
Created by
admin on Fri Dec 15 18:48:51 GMT 2023 , Edited by admin on Fri Dec 15 18:48:51 GMT 2023
|
PRIMARY | |||
|
Metkephamid
Created by
admin on Fri Dec 15 18:48:51 GMT 2023 , Edited by admin on Fri Dec 15 18:48:51 GMT 2023
|
PRIMARY | |||
|
SUB08899MIG
Created by
admin on Fri Dec 15 18:48:51 GMT 2023 , Edited by admin on Fri Dec 15 18:48:51 GMT 2023
|
PRIMARY | |||
|
66960-34-7
Created by
admin on Fri Dec 15 18:48:51 GMT 2023 , Edited by admin on Fri Dec 15 18:48:51 GMT 2023
|
PRIMARY | |||
|
C028208
Created by
admin on Fri Dec 15 18:48:51 GMT 2023 , Edited by admin on Fri Dec 15 18:48:51 GMT 2023
|
PRIMARY | |||
|
C174718
Created by
admin on Fri Dec 15 18:48:51 GMT 2023 , Edited by admin on Fri Dec 15 18:48:51 GMT 2023
|
PRIMARY | |||
|
4859
Created by
admin on Fri Dec 15 18:48:51 GMT 2023 , Edited by admin on Fri Dec 15 18:48:51 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |